Morgan Stanley
GOVX icon

Morgan Stanley’s GeoVax Labs GOVX Stock Holding History

Morgan Stanley’s Portfolio GOVX Stock Details GOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54K Buy
+83
New +$3.03K ﹤0.01% 7358
2026
Q1 		– Hold
0
– – – 8219
2025
Q4 		– Sell
-42
Closed -$11.1K – 8073
2025
Q3 		$11.9K Sell
42
-42
-50% -$17.6K ﹤0.01% 6853
2025
Q2 		$43.4K Sell
84
-86
-51% -$51.4K ﹤0.01% 6407
2025
Q1 		$108K Buy
+170
New +$180K ﹤0.01% 5972
2024
Q4 		– Sell
-1
Closed -$1.39K – 7382
2024
Q3 		$1.84K Sell
1
-1
-50% -$2.02K ﹤0.01% 7147
2024
Q2 		$4.47K Buy
+2
New +$2.11K ﹤0.01% 6876
2024
Q1 		– Hold
0
– – – 7296
2023
Q4 		– Sell
-6
Closed -$25.2K – 7169
2023
Q3 		$25.8K Hold
6
– – ﹤0.01% 6407
2023
Q2 		$27.6K Hold
6
– – ﹤0.01% 6445
2023
Q1 		$33.4K Hold
6
– – ﹤0.01% 6435
2022
Q4 		$36.1K Hold
6
– – ﹤0.01% 6433
2022
Q3 		$56K Buy
+6
New +$83K ﹤0.01% 6357
2022
Q2 		– Sell
-1
Closed -$10.6K – 7584
2022
Q1 		$6K Hold
1
– – ﹤0.01% 7539
2021
Q4 		$18K Buy
+1
New +$35.6K ﹤0.01% 7249
2021
Q3 		– Hold
0
– – – 7419
2021
Q2 		– Hold
0
– – – 7311
2021
Q1 		– Hold
0
– – – 7029

Other funds holding GOVX

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Two Sigma Securities
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Morgan Stanley's GOVX Position: Q2 2026 in Review

Morgan Stanley opened a new position in GeoVax Labs (GOVX) in Q2 2026: 83 shares worth $2.54K. The stake represents ﹤0.01% of the portfolio and ranks #7358 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in GOVX as recently as Q3 2025.

Morgan Stanley first reported a position in GOVX in Q4 2021 and has held it in 13 quarters since. The position peaked at $108K in Q1 2025. 14 funds tracked by Wall St. Rank hold GOVX as of Q2 2026.

  • Morgan Stanley held 83 shares of GeoVax Labs worth $2.54K as of Q2 2026.
  • GeoVax Labs was a new Morgan Stanley position in Q2 2026.
  • GeoVax Labs made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7358 holding.
  • Morgan Stanley first reported a position in GeoVax Labs in Q4 2021 and has held it in 13 quarters since.
  • Morgan Stanley's GeoVax Labs position peaked at $108K in Q1 2025.
  • 14 funds tracked by Wall St. Rank held GeoVax Labs as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.